Evidence map›Paper›PMID 29845470›Full record

ArticleJournal of general internal medicine2018

Development and Content Validation of a Patient-Reported Sexual Risk Measure for Use in Primary Care.

Rob J Fredericksen, Kenneth H Mayer, Laura E Gibbons, Todd C Edwards, Frances M Yang, Melonie Walcott, Sharon Brown, Lydia Dant, Stephanie Loo, Cristina Gutierrez and 10 more

Open access · bronzeAbstract readMulticenter StudyValidation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of general internal medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 1 country.

Rob J FredericksenCenter for AIDS Research, University of Washington, Seattle, WA, USA. rfrederi@uw.edu.
Kenneth H MayerFenway Community Health, Boston, MA, USA.
Laura E GibbonsCenter for AIDS Research, University of Washington, Seattle, WA, USA.
Todd C EdwardsCenter for AIDS Research, University of Washington, Seattle, WA, USA.
Frances M YangAugusta University, Augusta, GA, USA.
Melonie WalcottUniversity of Alabama, Birmingham, AL, USA.
Sharon BrownCenter for AIDS Research, University of Washington, Seattle, WA, USA.
Lydia DantFenway Community Health, Boston, MA, USA.
Stephanie LooFenway Community Health, Boston, MA, USA.
Cristina GutierrezFenway Community Health, Boston, MA, USA.
Edgar PaezUniversity of California, San Diego, CA, USA.
Emma FitzsimmonsCenter for AIDS Research, University of Washington, Seattle, WA, USA.
Albert W WuJohns Hopkins University, Baltimore, MD, USA.
Michael J MugaveroUniversity of Alabama, Birmingham, AL, USA.
William C MathewsUniversity of California, San Diego, CA, USA.
William B LoberCenter for AIDS Research, University of Washington, Seattle, WA, USA.
Mari M KitahataCenter for AIDS Research, University of Washington, Seattle, WA, USA.
Donald L PatrickCenter for AIDS Research, University of Washington, Seattle, WA, USA.
Paul K CraneCenter for AIDS Research, University of Washington, Seattle, WA, USA.
Heidi M CraneCenter for AIDS Research, University of Washington, Seattle, WA, USA.
University of Washington · USAIDS United · USFenway Health · USUniversity of Alabama at Birmingham · USUniversity of California, San Diego · USAugusta University · USJohns Hopkins University · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Kenneth Sherr · 1988 to 2026
$104.9M
Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4M
Patient reported outcomes in routine clinical care of patients infected with HIVU01AR057954 · NIAMS · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., CRANE, PAUL K · 2009 to 2013
$7.8M
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)U01AA020793 · NIAAA · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., LAU, BRYAN · 2011 to 2020
$5.8M
Integration of Evidence-based Alcohol Interventions into HIV CareU01AA020802 · NIAAA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CROPSEY, KAREN L, MUGAVERO, MICHAEL J · 2011 to 2020
$4.2M
Training in Health Services Research for Vulnerable PopulationsT32HS022242 · AHRQ · BOSTON MEDICAL CENTER · PI LAROCHELLE, MARC · 2013 to 2024
$4.1M
1/4 Alcohol Research Consortium in HIV-Administrative Core (ARCH-AC)U24AA020801 · NIAAA · JOHNS HOPKINS UNIVERSITY · PI CHANDER, GEETANJALI, MCCAUL, MARY E · 2011 to 2021
$3.5M
AHRQ HHS T32 HS022242NIAAA NIH HHS U01 AA020793NIAAA NIH HHS U01 AA020802NIAAA NIH HHS U24 AA020801NIAID NIH HHS P30 AI027757NIAID NIH HHS R24 AI067039NIAMS NIH HHS U01 AR057954
6 · The paper itself

Abstract

backgroundPatient-provider sexual risk behavior discussions occur infrequently but may be facilitated by high-quality sexual risk screening tools.

objectiveTo develop the Sexual Risk Behavior Inventory (SRBI), a brief computer-administered patient-reported measure.

designQualitative item development/quantitative instrument validation.

participantsWe developed SRBI items based on patient interviews (n = 128) at four geographically diverse US primary care clinics. Patients were diverse in gender identity, sex, sexual orientation, age, race/ethnicity, and HIV status. We compared sexual risk behavior identified by the SRBI and the Risk Assessment Battery (RAB) among patients (n = 422). APPROACH: We constructed an item pool based on validated measures of sexual risk, developed an in-depth interview guide based on pool content, and used interviews to elicit new sexual risk concepts. We coded concepts, matched them to item pool content, and developed new content where needed. A provider team evaluated item clinical relevance. We conducted cognitive interviews to assess item comprehensibility. We administered the SRBI and the RAB to patients. KEY

resultsCommon, clinically relevant concepts in the SRBI included number of sex partners; partner HIV status; partner use of antiretroviral medication (ART)/pre-exposure prophylaxis (PrEP); and recent sex without barrier protection, direction of anal sex, and concern regarding HIV/STI exposure. While 90% reported inconsistent condom use on the RAB, same-day SRBI administration revealed that for over one third, all their partners were on ART/PrEP.

conclusionThe SRBI is a brief, skip-patterned, clinically relevant measure that ascertains sexual risk behavior across sex, sexual orientation, gender identity, partner HIV serostatus, and partner treatment status, furnishing providers with context to determine gradations of risk for HIV/STI.

Indexed as

Patient Reported Outcome MeasuresRisk-TakingAdultAntiretroviral Therapy, Highly ActiveDiagnosis, Computer-AssistedFemaleGender IdentityHIV InfectionsHumansInterviews as TopicMaleMiddle AgedPrimary Health CareRisk AssessmentSexual BehaviorSexual Partnerspatient-reported outcomessexual risk behavior measurement

Identifiers

PMID29845470
PMCPMC6153230
OpenAlexW2805823854

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.